Conformational defects underlie proteasomal degradation of Dent's disease-causing mutants of CIC-5

被引:20
作者
D'Antonio, Christina [1 ,2 ]
Molinski, Steven [1 ,3 ]
Ahmadi, Saumel [1 ,2 ]
Huan, Ling-Jun [1 ]
Wellhauser, Leigh [1 ,2 ]
Bear, Christine E. [1 ,2 ,3 ]
机构
[1] Hosp Sick Children, Res Inst, Programme Mol Struct & Funct, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada
[3] Univ Toronto, Fac Med, Dept Biochem, Toronto, ON M5S 1A8, Canada
关键词
misfolded membrane protein; polyubiquitination; proteasome; unfolded protein response; TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPLASMIC-RETICULUM STRESS; CHLORIDE CHANNEL; IMPAIRS ENDOCYTOSIS; CLC-5; TRAFFICKING; MUTATIONS; 4-PHENYLBUTYRATE; DELTA-F508-CFTR; SELECTIVITY;
D O I
10.1042/BJ20121848
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mutations in the CLCN5 (chloride channel, voltage-sensitive 5) gene cause Dent's disease because they reduce the functional expression of the ClC-5 chloride/proton transporter in the recycling endosomes of proximal tubule epithelial cells. The majority (60 %) of these disease-causing mutations in ClC-5 are misprocessed and retained in the ER (endoplasmic reticulum). Importantly, the structural basis for misprocessing and the cellular destiny of such ClC-5 mutants have yet to be defined. A ClC-5 monomer comprises a short N-terminal region, an extensive membrane domain and a large C-terminal domain. The recent crystal structure of a eukaryotic ClC (chloride channel) transporter revealed the intimate interaction between the membrane domain and the C-terminal region. Therefore we hypothesized that intramolecular interactions may be perturbed in certain mutants. In the present study we examined two misprocessed mutants: C221R located in the membrane domain and R718X, which truncates the C-terminal domain. Both mutants exhibited enhanced protease susceptibility relative to the normal protein in limited proteolysis studies, providing direct evidence that they are misfolded. Interestingly, the membrane-localized mutation C221R led to enhanced protease susceptibility of the cytosolic N-terminal region, and the C-terminal truncation mutation R718X led to enhanced protease susceptibility of both the cytosolic C-terminal and the membrane domain. Together, these studies support the idea that certain misprocessing mutations alter intramolecular interactions within the full-length ClC-5 protein. Further, we found that these misfolded mutants are polyubiquitinated and targeted for proteasomal degradation in the OK (opossum kidney) renal epithelial cells, thereby ensuring that they do not elicit the unfolded protein response.
引用
收藏
页码:391 / 400
页数:10
相关论文
共 31 条
[11]   The CIC-5 chloride channel knock-out mouse -: an animal model for Dent's disease [J].
Günther, W ;
Piwon, N ;
Jentsch, TJ .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2003, 445 (04) :456-462
[12]   Potential Agents for Treating Cystic Fibrosis: Cyclic Tetrapeptides That Restore Trafficking and Activity of ΔF508-CFTR [J].
Hutt, Darren M. ;
Olsen, Christian A. ;
Vickers, Chris J. ;
Herman, David ;
Chalfant, Monica A. ;
Montero, Ana ;
Leman, Luke J. ;
Burkle, Renner ;
Maryanoff, Bruce E. ;
Balch, William E. ;
Ghadiri, M. Reza .
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (09) :703-707
[13]  
Hutt DM, 2010, NAT CHEM BIOL, V6, P25, DOI [10.1038/NCHEMBIO.275, 10.1038/nchembio.275]
[14]  
Katze M. G., 2002, P NATL ACAD SCI USA, V99, P15920
[15]   Expression and degradation of the cystic fibrosis transmembrane conductance regulator in Saccharomyces cerevisiae [J].
Kiser, GL ;
Gentzsch, M ;
Kloser, AK ;
Balzi, E ;
Wolf, DH ;
Goffeau, A ;
Riordan, JR .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 390 (02) :195-205
[16]   Suppressive effects of 4-phenylbutyrate on the aggregation of Pael receptors and endoplasmic reticulum stress [J].
Kubota, Kyoko ;
Niinuma, Yoshifumi ;
Kaneko, Masayuki ;
Okuma, Yasunobu ;
Sugai, Mami ;
Omura, Tomohiro ;
Uesugi, Mai ;
Uehara, Takashi ;
Hosoi, Toru ;
Nomura, Yasuyuki .
JOURNAL OF NEUROCHEMISTRY, 2006, 97 (05) :1259-1268
[17]   Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stones) disorders [J].
Lloyd, SE ;
Gunther, W ;
Pearce, SHS ;
Thomson, A ;
Bianchi, ML ;
Bosio, M ;
Craig, IW ;
Fisher, SE ;
Scheinman, SJ ;
Wrong, O ;
Jentsch, TJ ;
Thakker, RV .
HUMAN MOLECULAR GENETICS, 1997, 6 (08) :1233-1239
[18]   ClC-5 mutations associated with Dent's disease: a major role of the dimer interface [J].
Lourdel, Stephane ;
Grand, Teddy ;
Burgos, Johanna ;
Gonzalez, Wendy ;
Sepulveda, Francisco V. ;
Teulon, Jacques .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2012, 463 (02) :247-256
[19]   Nucleotide recognition by the cytoplasmic domain of the human chloride transporter ClC-5 [J].
Meyer, Sebastian ;
Savaresi, Sara ;
Forster, Ian C. ;
Dutzler, Raimund .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2007, 14 (01) :60-67
[20]   The chloride channel ClC-4 contributes to endosomal acidification and trafficking [J].
Mohammad-Panah, R ;
Harrison, R ;
Dhani, S ;
Ackerley, C ;
Huan, LJ ;
Wang, YC ;
Bear, CE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (31) :29267-29277